Derby Hospitals NHS Foundation Trust Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2019
NCT04289948
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Derby Hospitals NHS Foundation Trust | Royal Derby Hosptial | University Hospitals of Derby and Burton NHS Foundation Trust

Active Ingredients

Drugs in Phase 4 Trials (1)

remdesivir (Veklury) (1 trial)

Drugs in Phase 2 Trials (1)

anti-staphylococcus bacteriophage therapy (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 2)

Diabetic Foot (Phase 2)

Foot Ulcer (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2